Hematology Advisor

Latest

Machine Learning Algorithm Shows Promise in Determining BMF Etiology

Pirtobrutinib Produces Durable Responses in Relapsed/Refractory MCL

Changes to Primary Endpoints of Cancer Trials Are Not Being Disclosed in Manuscripts

Changes in Cancer Risk Factors, Screening Reported During Pandemic

Haploidentical Vs Matched Unrelated Donor Age Impacts Survival in Patients With ALL

New Risk Score Assists in Predicting Myeloid Neoplasms in Individuals With Clonal Hematopoiesis

Medical School Students Increasingly Come from Higher-Income Families

Few Cancer Drugs Are Approved Within 10 Years of Entering Trials

CDC Warns That Mpox Could Make a Summer Return

Study of Early Lymphopheresis for Relapsed/Refractory DLBCL Sheds Light on CAR-T Efficacy

Quizartinib Plus Chemotherapy Improves Survival Vs Placebo in FLT3-ITD-Positive AML

Recall: Oral Anesthetic Found in Cartons Labeled as Cough Suppressant

2011 to 2020 Saw Steady Improvement in Childhood Vaccine Adherence

Featured Content

Addressing the concerns of a caregiver.

Caring for the Caregivers of Patients With Hematologic Malignancies Undergoing HSCT

Researchers sought to address the needs of caregivers of patients with hematologic malignancies undergoing HSCT.

Weighing the Efficacy and Toxicity of CAR T-Cell Therapy

Researchers sought to determine the balance between the efficacy and toxicity when administering CAR T-cell therapy.

Centrifuged blood sample.

Disrupting the Status Quo: ACCESS Initiative Takes Aim at Inequities in HCT, Cellular Therapy

NMDP/Be The Match and the ASTCT seek to address inequities in HCT and cellular therapy.

Amazon’s Virtual Health Clinic Raises Patient Privacy Issues

How the retail giant will use the sensitive medical data it collects is among the concerns.

Browse drugs by:

Brand Generic Disease